Soothing and repairing composition and application thereof
Through the combination of chamomile extract and sea buckthorn fruit extract, the CaMK and PLC/PKC pathways are inhibited, and the problem that existing skin care products are difficult to alleviate sensitive skin symptoms is solved, achieving significant soothing and tolerability improvement effects.
Patent Information
- Application Number
- CN202411271560.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-11
- Publication Date
- 2024-11-08
AI Technical Summary
Existing skin care products are difficult to effectively alleviate the symptoms of sensitive skin itching, erythema, papules and edema caused by abnormal neurological function and immune inflammatory reactions, and have limited effect on improving skin tolerance.
The combination of chamomile extract and sea buckthorn fruit extract is used to reduce the release of histamine and other related substances by inhibiting the CaMK pathway and the PLC/PKC pathway, and to achieve the soothing effect of neurosedation and inflammatory skin reactions.
It significantly reduces allergic reactions, relieves skin sensitive symptoms, enhances the skin's tolerance to external irritations, and reduces heat and pain sensation, providing excellent soothing and repairing effects.
Smart Images

Figure CN118902947A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of skin care products, and in particular to a soothing and repairing composition and its application. Background Art
[0002] Due to the influence of environmental pollution, social pressure and personal factors, the skin has become more sensitive. More and more people are beginning to pay attention to their skin problems. As a result, the demand for functional skin care products that can soothe skin sensitivity has greatly increased.
[0003] Sensitive skin (SS) is characterized by low tolerance and high reactivity, and is generally considered to be the natural state of the skin's own structure and sensory nerves, rather than a skin disease. The skin is constantly exposed to a variety of endogenous, exogenous and lifestyle factors, which may affect the function of the skin barrier at the physical, mechanical and microbial levels, and may lead to inflammatory skin conditions involving sensitivity or irritation, and in severe cases, chronic inflammatory skin diseases, infections, allergies or autoimmune diseases. In sensitive skin, skin nerve dysfunction leads to increased nerve reactivity, activation of capsaicin receptor 1 (TRPV1) on cells, resulting in intracellular Ca 2+ Increased, triggering mast cell degranulation to release histamine, etc., causing sensitive skin neurogenic inflammation, vasodilation, edema, papules, itching, burning and other symptoms; at the same time, related chemokines and cytokines are produced to recruit immune cells, triggering or aggravating immune inflammatory response. Its mechanism may be through Ca 2+ Activation of the calmodulin kinase (CaMK) pathway and the phospholipase C / protein kinase C (PLC / PKC) pathway causes mast cell degranulation, triggering a series of reactions.
[0004] According to current research, sensitive skin is a complex process involving the skin barrier, nerve blood vessels, and immune inflammation. Recent studies at home and abroad have shown that most sensitive skin care products can increase skin moisture and repair the skin barrier to a certain extent, but have limited effects on improving itching, erythema, papules, and edema caused by abnormal nerve function and immune inflammatory response. Summary of the invention
[0005] The purpose of the present application is to overcome the deficiencies of the above-mentioned prior art and to provide a soothing and repairing composition and its application.
[0006] To achieve the above purpose, the technical solution adopted by this application is:
[0007] The present application provides a soothing and repairing composition, which comprises chamomile extract and sea buckthorn fruit extract;
[0008] The mass ratio of the chamomile extract to the seabuckthorn fruit extract is 1:(1-4).
[0009] In traditional Chinese medicine, seabuckthorn fruit has the effects of promoting blood circulation and removing blood stasis, resolving phlegm and relieving chest tightness, nourishing the spleen and stomach, promoting fluid production and quenching thirst, clearing away heat and stopping diarrhea. In modern medical research, it is called the "King of Vitamin C" and is widely accepted as an antioxidant medicinal and edible plant.
[0010] Chamomile, its flavonoids account for 0.5% of chamomile, the main flavonoids are apigenin, luteolin, quercetin. In addition, there are a variety of flavonol glycosides, which are the main anti-inflammatory ingredients, and the polysaccharides isolated from chamomile inflorescences also have anti-inflammatory effects. Some components in chamomile, such as volatile oils and flavonoids, also have inhibitory effects on Trichophyton rubrum, Trichophyton mentagrophytes, and Candida albicans. Chamomile volatile oil is stronger than garlic in inhibiting Bacillus larvae.
[0011] This application integrates the mechanisms related to nerve sedation and relief of skin inflammatory reactions as a soothing activity orientation to develop Chinese herbal active ingredient raw materials with soothing effects, aiming to prevent or relieve a series of symptoms caused by sensitive skin being stimulated.
[0012] The inventors of the present application have found through a large number of experiments that when chamomile extract and seabuckthorn fruit extract are used in combination, they exhibit very excellent effects on nerve sedation and relief of skin inflammatory reactions; and the effects of chamomile extract and seabuckthorn fruit extract on Ca 2+ Related pathways - CaMK, a key indicator of the CaMK pathway; PLC / PKC, a key indicator of the PLC / PKC pathway, and the phosphorylation levels of PKC proteins; the synergistic use of chamomile extract and seabuckthorn fruit extract shows a soothing mechanism of action. This application uses the above two extracts in synergy, which can act directly on the skin when used externally, with high safety and significant effects. The experimental results show that it does have a good soothing and repairing effect.
[0013] The synergistic combination of chamomile extract and sea buckthorn fruit extract in a mass ratio of 1:(1-4) can more effectively inhibit the degranulation of RBL-2H3 cells, synergistically inhibit histamine and other related substances, and has significant soothing activity.
[0014] As a preferred embodiment of the soothing and repairing composition described in the present application, the mass ratio of the chamomile extract to the sea buckthorn fruit extract is 1:1 or 1:2.
[0015] In the present application, the two strongest combination ratios of chamomile extract and sea buckthorn fruit extract for antihistamine synergistic effect are 1:1 and 1:2. The combined use is better than single drug use, and with increasing concentration, the histamine inhibition rate is enhanced, and the soothing activity is the best.
[0016] The above combination shows a relatively excellent inhibitory effect on the release of related pathway factors in RBL-2H3 cells. By inhibiting the influx of calcium ions, the release of TNF-α, histamine and β-hexosaminidase, MCP-1, TNF-α, and IL-4 is reduced, thereby allergic reactions are alleviated, and skin sensitivity symptoms are relieved to soothe the skin, enhance the skin's resistance to external stimuli, and strengthen the skin's tolerance to stimuli. By inhibiting the expression of TRPV1 protein, the uncomfortable sensations such as heat and pain caused by external stimuli to the skin are reduced.
[0017] As a preferred embodiment of the soothing and repairing composition described in the present application, the mass concentration of the chamomile extract is 1 to 16 μg / ml; the mass concentration of the sea buckthorn fruit extract is 1 to 16 μg / ml.
[0018] In some specific embodiments, the mass concentration of the chamomile extract is 4 to 16 μg / ml; the mass concentration of the sea buckthorn fruit extract is 4 to 16 μg / ml. With the increase of the mass concentration of the chamomile extract or the sea buckthorn fruit extract, the histamine inhibition rate is enhanced, and the calcium ion influx is better inhibited, the expression of TRPV1 protein is inhibited, and the release of TNF-α, histamine and β-hexosaminidase, MCP-1, TNF-α, and IL-4 is reduced, thereby achieving a soothing and repairing effect.
[0019] As a preferred embodiment of the soothing and repairing composition described in the present application, the soothing and repairing composition further comprises a fermentation complex;
[0020] The fermentation complex is obtained by fermenting Pediococcus pentosaceus and white tea.
[0021] The present application also found that fermenting Pediococcus pentosaceus and white tea to obtain a fermentation complex, and then combining it with chamomile extract and sea buckthorn fruit extract, has a better antihistamine synergistic effect and can achieve better soothing and repairing effects.
[0022] As a preferred embodiment of the soothing and repairing composition described in the present application, the mass ratio of the chamomile extract, the sea buckthorn fruit extract and the fermentation complex is 1:1:(0.4-0.8).
[0023] The present application adds a fermentation complex to the composition, and when it is combined with chamomile extract and sea buckthorn fruit extract in the above mass ratio, the antihistamine effect is better.
[0024] As a preferred embodiment of the soothing and repairing composition of the present application, the preparation method of the fermentation complex comprises the following steps:
[0025] The seed liquid of Pediococcus pentosaceus is inoculated into a culture medium containing white tea powder for fermentation to obtain the fermentation complex.
[0026] As a preferred embodiment of the soothing and repairing composition of the present application, the inoculation amount of the Pediococcus pentosaceus seed solution is 1 to 3%;
[0027] The culture medium containing white tea powder comprises the following components in percentage by mass:
[0028] 0.4-1% white tea powder, 2-4% glucose, 0.5-1.5% soy peptone, and the balance is water.
[0029] In some specific embodiments, the fermentation temperature is 27° C. to 33° C., and the fermentation time is 24 to 48 hours.
[0030] In some specific embodiments, the method for preparing a seed solution of Pediococcus pentosaceus comprises the following steps:
[0031] The bacterial suspension of Pediococcus pentosaceus is inoculated into a YM solid culture medium for activation culture, wherein the activation culture temperature is 27 to 35° C. and the activation culture time is 24 to 48 hours to obtain activated Pediococcus pentosaceus;
[0032] The activated Pediococcus pentosaceus is inoculated into a YM liquid culture medium for expansion at a temperature of 27 to 35° C. for 24 to 48 hours to obtain the Pediococcus pentosaceus seed solution.
[0033] As a preferred embodiment of the soothing and repairing composition described in the present application, the preparation method of the chamomile extract comprises the following steps:
[0034] Chamomile is ground into powder, 70-90% ethanol is added for ultrasonic extraction, then filtered, and then preparative liquid chromatography is used to separate and purify the enriched substances, and flavonoid compound segment samples are taken and dried to obtain yellow powder to obtain chamomile extract.
[0035] As a preferred embodiment of the soothing and repairing composition described in the present application, the preparation method of the seabuckthorn fruit extract comprises the following steps:
[0036] The seabuckthorn fruit is ground into powder, 50-70% ethanol by volume is added for ultrasonic extraction, and then filtered. The enriched material is separated and purified by liquid chromatography, and the proanthocyanidin segment sample is taken and dried to obtain wine red powder to prepare the seabuckthorn fruit extract.
[0037] The chamomile extract and sea buckthorn fruit extract of the present application adopt ultrasonic microwave assisted extraction-liquid phase (UAE-LC) extraction technology to obtain chamomile extract and sea buckthorn fruit extract with higher active substances.
[0038] In some specific embodiments, in the preparation method of the seabuckthorn fruit extract, the solid-liquid ratio of seabuckthorn fruit powder and ethanol is 1:20, the ultrasonic temperature is 60°C, the power is 200w, and the ultrasonic extraction is 20min; 200-mesh nylon filter cloth is used for coarse filtration and organic membrane filtration is used.
[0039] In some specific embodiments, in the preparation method of the chamomile extract, the solid-liquid ratio of chamomile powder and ethanol is 1:25; the ultrasonic temperature is 80°C, the power is 200w, and the ultrasonic extraction is 25min; 200-mesh nylon filter cloth is used for coarse filtration and organic membrane filtration; wherein the volume fraction of ethanol is preferably 80% ethanol (80 parts of ethanol, 20 parts of weak alkaline water with a pH of 8 adjusted by NaHCO3).
[0040] The present application also provides the use of the soothing and repairing composition in the preparation of skin care products.
[0041] From the test results, the present invention provides a soothing composition and preparation, which has a good therapeutic effect. Early and mid-term users have relief, and mild patients have a good skin soothing management effect. Therefore, developing efficient, green and environmentally friendly skin soothing products to achieve the purpose of healthy whitening is a new trend in the development of cosmetics in the future. Cosmetics pursue natural, harmless and green, beautify the appearance of the skin while improving the skin's resistance to external stimuli, making the skin more resistant to irritation and healthy, and have huge market potential.
[0042] Compared with the prior art, this application has the following beneficial effects:
[0043] The present application provides a soothing repair composition and its application. The soothing repair composition provided by the present application has a synergistic antihistamine effect, and the soothing repair composition shows a relatively excellent inhibitory effect on the release of related pathway factors in RBL-2H3 cells. By inhibiting the influx of calcium ions, reducing the release of TNF-α, histamine and β-hexosaminidase, MCP-1, TNF-α, and IL-4, allergic reactions are alleviated, and the sensitive symptoms of the skin are relieved to soothe the skin, enhance the skin's resistance to external stimuli, and strengthen the skin's tolerance to stimuli. By inhibiting the expression of TRPV1 protein, the uncomfortable sensations such as heat and pain caused by external stimuli to the skin are reduced. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] Figure 1 The effect of chamomile extract and sea buckthorn fruit extract on RBL-2H3 cell viability
[0045] n=6, Note: Compared with the normal group, **** P<0.0001);
[0046] Figure 2The effect of chamomile extract and seabuckthorn fruit extract on histamine content in RBL-2H3 cell model n=6, Note: Compared with the model group, **** P<0.0001);
[0047] Figure 3 The effect of chamomile extract and seabuckthorn fruit extract on β-hex content in RBL-2H3 cell model n=6, Note: Compared with the model group, **** P<0.0001; compared with the paeonol group, ++++ P<0.0001; compared with ketotifen, #### P<0.0001);
[0048] Figure 4 The effect of different drug concentrations on histamine n=6, Note: A is sea buckthorn fruit extract, B is chamomile extract, C is chamomile: sea buckthorn fruit = 1:1, D is chamomile: sea buckthorn fruit = 2:1, E is chamomile: sea buckthorn fruit = 4:1, F is chamomile: sea buckthorn fruit = 1:2, G is chamomile: sea buckthorn fruit = 1:4);
[0049] Figure 5 The combined index curves of extracts with different ratios (Note: C is chamomile: sea buckthorn fruit = 1:1, D is chamomile: sea buckthorn fruit = 2:1, E is chamomile: sea buckthorn fruit = 4:1, F is chamomile: sea buckthorn fruit = 1:2, G is chamomile: sea buckthorn fruit = 1:4);
[0050] Figure 6 The effect of the extract composition on histamine at different concentrations is shown in FIG. n=6, Note: A is seabuckthorn fruit extract, B is chamomile extract, C is chamomile: seabuckthorn fruit = 1:1; C compared with A group, *P<0.1, C compared with B group # P<0.1);
[0051] Figure 7 The effect of composition C on degranulation of RBL-2H3 cell model n=6);
[0052] Figure 8 The effect of composition C on the β-hex content of RBL-2H3 cell model n=6, Note: Compared with the model group, ****P<0.0001; compared with the paeonol group, ++++ P<0.0001);
[0053] Fig. 9 The effect of composition C on the MCP-1 content of RBL-2H3 cell model n=6, Note: Compared with the model group, ****P<0.0001; compared with the paeonol group, +P<0.05, ++++P<0.0001);
[0054] Fig.10 The effect of composition C on TNF-α content in RBL-2H3 cell model n=6, Note: Compared with the model group, ****P<0.0001, compared with the paeonol group, ++P<0.01);
[0055] Fig.11 The effect of composition C on IL-4 content in RBL-2H3 cell model n=6, Note: Compared with the model group, **P<0.001, ****P<0.0001; compared with the paeonol group, +P<0.05, ++P<0.01);
[0056] Fig.12 The effect of composition C on the protein content of capsaicin receptor TRPV1 in RBL-2H3 cell model n=6, Note: Compared with the model group, ****P<0.0001, compared with the paeonol group, +++P<0.001, ++++P<0.0001). DETAILED DESCRIPTION
[0057] In order to better illustrate the purpose, technical solutions and advantages of the present application, the present application will be further described below in conjunction with the accompanying drawings and specific embodiments.
[0058] In the following examples and comparative examples, the experimental methods used are conventional methods unless otherwise specified, and the materials, reagents, etc. used are all commercially available unless otherwise specified, and the components and raw materials used in each parallel experiment are of the same type.
[0059] The present application provides a method for preparing seabuckthorn fruit extract (using ultrasonic microwave assisted extraction-liquid phase (UAE-LC) combined preparation technology), comprising the following steps:
[0060] Take 50g of seabuckthorn fruit medicinal material, grind it into powder, add 60% ethanol by volume as the extraction solvent, the solid-liquid ratio of powder to ethanol is 1:20, put it into the ultrasonic extraction tank, the ultrasonic temperature is 60℃, the power is 200w, the ultrasonic extraction time is 20min, the effective ingredients in the medicinal material cells are released, 200 mesh nylon filter cloth is used for coarse filtration, organic membrane filtration is used, and then enters the combined preparation liquid phase for separation, purification and enrichment. The specific liquid phase column specifications are: Agilent ZORBAXStableBond C18 column (250mm*9.4mm, 5μm); the mobile phase is pure methanol, the elution time is 30min; the flow rate is 3ml / min, and the mobile phase needs to be ultrasonically degassed before use; the injection volume is 500μl; the detection wavelength is 289nm; the column temperature: 40℃; the sample retention time is 15min~24min, and the proanthocyanidin segment sample is taken. After the sample is dried, a wine-red powder is obtained and set aside, which is recorded as sample A. Sample A described below is the sea buckthorn fruit extract.
[0061] The present application provides a method for preparing a chamomile extract (using ultrasonic microwave assisted extraction-liquid phase (UAE-LC) combined preparation technology), comprising the following steps:
[0062] Take 50g of chamomile medicinal material, grind it into powder, add 80% ethanol (80 parts ethanol, 20 parts NaHCO3 adjusted pH 8 weak alkaline water) as the extraction solvent, the solid-liquid ratio of powder to ethanol is 1:25, put it into the ultrasonic extraction tank, the ultrasonic temperature is 80℃, the power is 200w, the ultrasonic extraction time is 25min, the effective ingredients in the medicinal material cells are released, 200 mesh nylon filter cloth is used for coarse filtration, organic membrane filtration is used, and it enters the combined preparation liquid phase for separation, purification and enrichment, specifically: Agilent ZORBAX StableBond C18 column (250mm*9.4mm, 5μm); mobile phase is acetonitrile: water (35:65), elution time is 30min; flow rate is 3ml / min, and the mobile phase needs to be ultrasonically degassed before use; injection volume is 500μl; detection wavelength is 256nm; column temperature: 40℃; sample retention time is 10min~15min, take flavonoid compound section sample, and after the sample is dried, it becomes yellow powder for standby use and is recorded as sample B. Sample B mentioned below is chamomile extract.
[0063] Pediococcus pentosaceus is a conventional strain (for example, Pediococcus pentosaceus can be derived from Shandong Poly Chemical Co., Ltd.), which is commercially available.
[0064] Example 1: Effects of seabuckthorn fruit extract and chamomile extract on RBL-2H3 cell viability
[0065] MTT experiment was used to detect the effects of samples A and B on cell viability. The concentrations of A were set at 1μg / ml, 2μg / ml, 4μg / ml, 8μg / ml, 16μg / ml, and 32μg / ml, and the concentrations of B were set at 0.625μg / ml, 1.25μg / ml, 2.5μg / ml, 5μg / ml, 10μg / ml, and 20μg / ml. Paeonol and ketotifen were used as positive drugs for comparison.
[0066] 1.1 Experimental cells:
[0067] Rat basophil leukemia cells (RBL-2H3), catalog number CL-0192, were purchased from Wuhan Pronocell Life Science Technology Co., Ltd.
[0068] 1.2 Preparation of drug and reagent stock solutions:
[0069] Preparation of drug stock solution: Use DMSO as solvent to prepare drug stock solution with positive drugs paeonol, ketotifen, sea buckthorn fruit extract and chamomile extract. After sterilization by filtration with 0.22μm pore size filter membrane, dispense into EP tubes, seal and mark drug information, and store at -20℃ in a dark environment for later use. Add calculated amount of 1640 serum-free medium to dilute A stock solution to prepare 64μg / ml drug solution, and add calculated amount of 1640 serum-free medium to dilute B drug solution stock solution to prepare 40μg / ml drug solution, seal and mark, and store in a 4℃ refrigerator for later use.
[0070] Prepare MTT working solution: weigh 50.00 mg of MTT powder and add it to a 15 mL centrifuge tube. Transfer the centrifuge tube to a clean bench and add 10.0 mL of PBS solution and shake to completely dissolve it to make a 5 mg / mL working solution. Filter and sterilize with a 0.22 μm pore size filter membrane, seal the tube, mark the relevant information, and store at -20°C away from light for future use.
[0071] Preparation of calcium ion carrier A23187 solution: Weigh 5 mg of calcium ion carrier A23187 powder, add it into a 1.5 mL centrifuge tube, transfer it to the clean bench environment, add 1 mL of DMSO solution and shake it to completely dissolve it to make a 5 mg / mL calcium ion carrier A23187 solution. Seal the tube and mark the relevant information. After aliquoting, store it at -20°C away from light for later use.
[0072] 1.3 Experimental steps:
[0073] RBL-2H3 cells were cultured at 2×10 5Cells were inoculated at a density of 100 μL / mL in a 96-well plate, 100 μL per well, and placed in a 37°C cell culture incubator for 24 hours to reach the logarithmic growth phase (cells are about 70%-80% confluent), the original 1640 complete medium was removed, and PBS was added to wash the cells twice. 100 μL of 1640 medium without drugs was added to each well of the normal group, and 100 μL of 1640 medium containing different concentrations of drugs was added to each well of the drug-treated group, and the plates were placed in a cell culture incubator for further culturing for 12 hours.
[0074] The MTT experiment was used to detect the effect of drugs on cell viability. The specific steps are as follows: after culturing for 12 hours with drug addition, the original 1640 medium was discarded, washed twice with PBS, and the 5 mg / mL MTT working solution was diluted 10 times to 0.5 mg / mL with 1640 medium under light-proof conditions, and 100 μL of 0.5 mg / mL MTT solution was added to each well, and cultured in a light-proof incubator for 4 hours, the plate was removed, the liquid was discarded, and washed twice with PBS, and 100 μL of DMSO was added to each well, fully dissolved for 10 minutes, and the OD value at 490 nm was detected with an enzyme reader within 10 minutes, and the cell viability was calculated.
[0075] Experimental Results Figure 1 As shown, compared with the normal group, when the ketotifen concentration was higher than 32μM and the chamomile extract concentration was higher than 20μg / ml, the cell viability was greatly affected. Under the action of the drug, the viability of RBL-2H3 cells was lower than 85%, affecting the normal growth of cells. Therefore, in order to avoid the drug affecting the normal growth of cells and thus affecting the experimental results, the concentrations of seabuckthorn fruit extract and chamomile extract were set to 32μg / ml and 10μg / ml respectively in subsequent experimental studies, and the concentrations of paeonol and ketotifen were uniformly set to 32μM.
[0076] Example 2: Effects of seabuckthorn fruit extract and chamomile extract on histamine β-hex content in RBL-2H3 cell degranulation model
[0077] According to the experimental results of Example 1, the concentrations of seabuckthorn fruit extract and chamomile extract were set to 32 μg / ml and 10 μg / ml respectively, and the administration concentrations of paeonol and ketotifen were uniformly set to 32 μM.
[0078] 2.1 Experimental steps:
[0079] A blank group, a paeonol group (positive drug), a ketotifen group (positive drug) and an extract group were set up, with 6 replicate wells in each group. 5Each well of the 24-well plate was inoculated with 0.5 mL per well, cultured for 24 hours, the supernatant was discarded, and each well was washed twice with 0.5 mL PBS. The calcium ion carrier A23187 with a concentration of 800 ng / mL was added to each well of the model group and the drug group, the sea buckthorn fruit extract group was added with a concentration of 32 μg / ml per well, and the chamomile extract group was added with a concentration of 10 μg / ml per well. Only 1640 medium was added to each well of the blank group as a control. Incubated at 37°C for 30 minutes, the cell culture supernatant was collected and stored at -20°C for later use.
[0080] 2.2 Experimental results:
[0081] The effect on histamine content was tested using an ELISA kit. The samples were processed according to the method of the kit. The results are as follows:
[0082] Table 1 Effects of extracts on HIS content in RBL-2H3 cell model n=6)
[0083]
[0084] The effects of the two extracts on RBL-2H3 degranulation cells were detected by spectrophotometry. The test results are as follows:
[0085] Table 2 Effects of extracts on β-hex content in RBL-2H3 cell model ( n=6))
[0086]
[0087] From the above Table 1, Table 2, Figure 2 , Figure 3 It can be seen that chamomile extract and sea buckthorn fruit extract have relatively excellent effects in reducing histamine secretion and relatively significant effects in reducing β-hex release. It can be preliminarily judged that the two extracts have relatively good inhibitory effects on histamine and β-hex, especially the inhibitory effect on β-hex is better than the positive drugs paeonol and ketotifen.
[0088] Example 3: Synergistic antihistamine effect of chamomile extract and seabuckthorn fruit extract
[0089] This example found that chamomile extract and sea buckthorn fruit extract have a synergistic antihistamine effect, so this example will continue to use RBL-2H3 cell degranulation as a model and histamine as an indicator to explore the effect of the combination of chamomile extract and sea buckthorn fruit extract on the histamine content, calculate the combination index of the combination, draw a combination index curve, determine the combination ratio with the strongest antihistamine synergistic effect, compound chamomile extract and sea buckthorn fruit extract into a composition, explore the effect of the composition on cell viability, and determine the dosage concentration for subsequent experiments.
[0090] The histamine content was used as an indicator combined with CompuSyn software to analyze the combined effects of different proportions of chamomile extract and sea buckthorn fruit extract.
[0091] 3.1 Experimental cells:
[0092] Rat basophil leukemia cells (RBL-2H3), catalog number CL-0192, were purchased from Wuhan Pronocell Life Science Technology Co., Ltd.
[0093] 3.2 Cell grouping and drug administration:
[0094] Example 2 Experimental results The single drug concentrations of the chamomile extract group and the sea buckthorn fruit extract group were set to 1μg / ml, 2μg / ml, 4μg / ml, 8μg / ml, and 16μg / ml. The combined ratio (mass ratio) of the chamomile extract and sea buckthorn fruit extract combination group was set to 4:1 (for example, 1μ / ml: the dosage of chamomile extract was 0.8μg / ml, and the dosage of sea buckthorn fruit extract was 0.2μg / ml), 2:1 (1μ / ml: the dosage of chamomile extract was 0.67μg / ml, and the dosage of sea buckthorn fruit extract was 0.33μg / ml), 1:1 (1μ / ml: the dosage of chamomile extract was 0.67μg / ml, and the dosage of sea buckthorn fruit extract was 0.33μg / ml), The dosage of the extract was 0.5 μg / ml, the dosage of seabuckthorn fruit extract was 0.5 μg / ml), 1:2 (1 μ / ml: the dosage of chamomile extract was 0.33 μg / ml, the dosage of seabuckthorn fruit extract was 0.67 μg / ml) and 1:4 (1 μ / ml: the dosage of chamomile extract was 0.2 μg / ml, the dosage of seabuckthorn fruit extract was 0.8 μg / ml), 3 replicates each. Other cell treatments were as in Example 1.
[0095] 3.3 Determination of histamine content:
[0096] RBL-2H3 was added at 2×10 5 Each well of the model group and the drug group was added with calcium ion carrier A23187 at a concentration of 800ng / mL, and each well of the drug group was added with different Chinese medicine monomer chemical components at a concentration of 32μM. The blank group was added with only 1640 culture medium as a control. Incubate at 37℃ for 30min, collect the cell culture supernatant, and determine the histamine content of each group of cells according to the instructions of the enzyme-linked immunosorbent assay (ELISA) kit, and calculate the histamine inhibition rate of each concentration group of chamomile extract, sea buckthorn fruit extract, and each ratio concentration group of combined drug use according to the following formula.
[0097]
[0098] 3.4 Calculation of combined medication index:
[0099] CompuSyn software was used to calculate and analyze the combination index (CI) of drug combination therapy. The calculation formula was CI = D1 / D X ,1+D2 / D X,2 ; Wherein, D1 and D2 represent the concentrations of the two drugs when the histamine inhibition rate of the combined use of chamomile extract and seabuckthorn fruit extract reaches X, and D X,1 , D X,2 These are the concentrations corresponding to when the histamine inhibition rate reaches X when chamomile extract and seabuckthorn fruit extract are used alone. The combined effect of chamomile extract and seabuckthorn fruit extract indicates:
[0100] ①CI<1: indicates that the drug combination has a synergistic effect;
[0101] ②CI=1: indicates that the drug combination has an additive effect;
[0102] ③CI>1: indicates that the drug combination has antagonistic effects.
[0103] Draw a combination index curve. Draw a combination index curve with the histamine inhibition rate as the horizontal axis and the combination index CI value as the vertical axis, observe the relationship between the histamine inhibition rate and the combination index, and obtain the ratio of chamomile extract and sea buckthorn fruit extract with the strongest synergistic effect and form a combination for subsequent product development research.
[0104] like Figure 4 As shown in the figure, at a certain concentration, the combined use of chamomile extract and sea buckthorn fruit extract in a ratio of 1:1 is better than the single drug use, and the histamine inhibition rate increases with the increase in concentration. When the concentration is above 4μg / ml, the inhibitory effect on histamine in the combined use of group C gradually increases, so the subsequent experiments can be carried out with a concentration of 4μg / ml or above for the experimental invention. According to the above figure, a combined application index CI curve can be drawn, as shown in Figure 5 shown.
[0105] like Figure 5 As shown, when the ratio of chamomile extract to sea buckthorn fruit extract is 1:1 and 1:2, the corresponding CI value is less than 1, and the ratio of chamomile extract to sea buckthorn fruit extract is 1:1 and 1:2, which has a synergistic anti-histamine effect. The lower the CI value, the stronger the synergistic effect. The CI values of different histamine inhibition rates in the 1:1 ratio are all less than the corresponding 1:2 ratio, indicating that when the same histamine inhibition rate can be achieved, the lower the concentration of the combined drug required in the 1:1 ratio, the stronger the synergistic effect. Therefore, the subsequent experimental invention was conducted by combining chamomile extract and sea buckthorn fruit extract in a 1:1 ratio.
[0106] Table 3 Effect of extract composition at different concentrations on the action of histamine n=6)
[0107]
[0108]
[0109] As shown in Table 3 and Figure 6 As shown, when the concentration is above 4 μg / ml, the combined use of group C is significantly higher than that of group A and group B, respectively, with P < 0.1, and the inhibitory effect on histamine is gradually enhanced. Therefore, in subsequent experiments, the concentration of composition C above 4 μg / ml can be used for experimental application, that is, 4 μg / ml, 8 μg / ml, and 16 μg / ml are selected as the low, medium, and high doses of the composition, respectively, for subsequent experimental research inventions.
[0110] Example 4: Effect of Composition C on RBL-2H3 Cell Model
[0111] The specific ratio and concentration of the combined application are determined in Example 3. The effect of the combination on the degranulation of RBL-2H3 cells was further explored by toluidine blue staining.
[0112] Monocyte chemoattractant protein MCP-1 can recruit immune cells (macrophages, T lymphocytes and eosinophils, etc.) to migrate to the local skin, causing skin immune inflammatory response; TNF-α and IL-4 are key factors in the NF-κB and JAK-STAT signaling pathways activated downstream of the PLC / PKC pathway, expanding the inflammatory response pathway; capsaicin receptor (TRPV1) protein is an ion channel that opens when the RBL-2H3 cell model degranulates, further promoting Ca 2+ internal flow.
[0113] The in vitro soothing activity of the composition was comprehensively evaluated by detecting different substances released by the composition on the RBL-2H3 cell model. Therefore, the example will explore the effect of the composition on the RBL-2H3 cell model, and use the ELISA method to detect the effect of the composition on the content of MCP-1, TNF-α, IL-4, and TRPV1 proteins.
[0114] 4.1 Experimental cells:
[0115] Rat basophil leukemia cells (RBL-2H3), catalog number CL-0192, were purchased from Wuhan Pronocell Life Science Technology Co., Ltd.
[0116] 4.2 Experimental steps:
[0117] Cell grouping and drug administration. According to the experimental results, the low, medium and high dose concentrations of the composition were determined to be 4 μg / ml, 8 μg / ml and 16 μg / ml, respectively, and the concentration of the positive drug paeonol was set to 32 μM. A normal group, a model group, a paeonol group, a low dose group of composition C, a medium dose group of composition C and a high dose group of composition C were set, and 3 replicates were set for each group.
[0118] Toluidine blue staining method experimental steps. RBL-2H3 cells were plated at 2×10 5 Cells were inoculated at a density of 100 μg / mL in a 24-well plate, 500 μL per well, and incubated in a 37°C cell culture incubator for 24 hours. The original 1640 complete medium was removed, and the cells were washed with PBS 1-2 times. Calcium ion carrier A23187 at a concentration of 800 ng / mL was added to each well of the model group and the drug group. 1640 medium containing different concentrations of drugs at a concentration of 32 μM was added to each well of the drug group, and the corresponding volume of 1640 medium was added to each well of the model group. Only the corresponding volume of 1640 medium was added to each well of the normal group as a control. The cells were incubated at 37°C for 30 minutes, and the cell degranulation was detected.
[0119] After terminating the reaction, the culture medium was discarded, the cells were washed twice with PBS, fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.1% Triton X-100 for 3-5 min, stained with 1% toluidine blue dye for 30 cm, washed twice with appropriate amount of PBS, and cell degranulation was observed under an inverted microscope.
[0120] 4.3 Effect of composition C on β-hex content in RBL-2H3 cell model:
[0121] The cells were cultured in the same manner as described in 4.2, and the effects of chamomile extract and seabuckthorn fruit extract composition C on the β-hex content of the RBL-2H3 cell model were detected by spectrophotometry. The corresponding blank group and drug administration group and drug administration concentration were set, and the cells were cultured normally and stimulated and administered, and the cell culture supernatant was collected, and the OD value was measured at 405nm on an ELISA instrument, and the β-hex inhibition rate was calculated by substituting it into the following formula.
[0122]
[0123] 4.4 Effect of Composition C on the Content of MCP-1, TNF-α, IL-4 and TRPV1 Proteins in RBL-2H3 Cell Model:
[0124] The cells were cultured using the same experimental method as described in 4.2, and the ELISA method was used to detect the effect of composition C on the levels of MCP-1, TNF-α, and IL-4, signaling molecules in the RBL-2H3 cell model. Corresponding blank groups and drug-treated groups and drug-treated concentrations were set up. After normal cell culture and stimulation and drug administration, the cell culture supernatant was collected and measured according to the instructions of the ELISA kit.
[0125] The cells were cultured with the experimental method described in 4.2, and the effect of composition C on the TRPV1 protein content of the RBL-2H3 cell model was detected by Elisa method. The corresponding blank group and the drug administration group and the drug administration concentration were set up. After the cells were cultured normally and stimulated and administered, the reaction was terminated and the culture medium was discarded. 200uL of 1% Triton X-100 lysis solution was added to each well, and the cells were lysed in a 4°C refrigerator for 1h. The collected lysed cell suspension was transferred to a 1.5mL centrifuge tube and centrifuged at 5000rpm in a low-temperature refrigerated centrifuge for 20min. The TRPV1 protein content was determined according to the instructions of the ELISA kit.
[0126] 4.5 Experimental results:
[0127] The results are as follows:
[0128] like Figure 7 As shown, compared with the model group, the degranulation degree in the medium-dose and high-dose groups of the composition was alleviated, the cell vacuolar structure was reduced, and the extracellular granular substances were reduced.
[0129] The effect of composition C on the β-hex content in the RBL-2H3 cell model was detected by spectrophotometry. The experimental results are as follows: Figure 8 Compared with the model group, the low-dose group, medium-dose group, and high-dose group of the combination significantly down-regulated the β-hex content (P value < 0.0001); compared with the paeonol group (positive drug), the medium-dose group and high-dose group of the combination significantly down-regulated the β-hex content (P value < 0.0001), and the effect was better than that of the paeonol in the positive drug group.
[0130] like Figure 9-12 As shown, compared with the model group, the medium-dose group and high-dose group of composition C significantly reduced the MCP-1 content (P value <0.0001); compared with the paeonol group (positive drug), the medium-dose group and high-dose group of the composition significantly reduced the MCP-1 content (P value <0.05, P value <0.0001).
[0131] Compared with the model group, the low-dose group, medium-dose group, and high-dose group of composition C significantly reduced the TNF-α content (P value < 0.0001); compared with the paeonol group (positive drug), the medium-dose group and high-dose group of the composition significantly reduced the TNF-α content (P value < 0.01).
[0132] The low-dose group, medium-dose group and high-dose group of composition C all significantly reduced the IL-4 content (P value <0.0001); compared with the paeonol group (positive drug), the medium-dose group and high-dose group of the composition significantly reduced the IL-4 content (P value <0.05, P value <0.01).
[0133] Compared with the model group, the low-dose group, medium-dose group and high-dose group of composition C significantly down-regulated the TRPV1 protein content in the RBL-2H3 cell model (P value <0.0001); compared with the paeonol group (positive drug), the medium-dose group and high-dose group of the composition significantly down-regulated the TRPV1 protein content in the RBL-2H3 cell model (P value <0.001, P value <0.0001).
[0134] From the above figures, it can be observed that compared with the model group, the composition C has a very significant inhibitory effect on the expression of β-hex, MCP-1, TNF-α, IL-4, and TRPV1 proteins, and its effect is significantly better than that of the positive drug paeonol group.
[0135] It is known that after activation, RBL-2H3 cells secrete and release mediators and inflammatory factors (such as histamine, protease, eicosanoid compounds, cytokines, etc.), which trigger allergic reactions. This process is called mast cell degranulation. Among the various mediators released, histamine is the most characteristic and most effective vasoactive mediator and is considered to be a sign of degranulation. Therefore, allergic symptoms can be alleviated by reducing the release of mediators (histamine, protease, cytokines, etc.).
[0136] From the above results, it can be seen that the C composition shows a relatively excellent inhibitory effect on the release of related pathway factors in RBL-2H3 cells. By inhibiting the influx of calcium ions, the release of TNF-α, histamine and β-hexosaminidase, MCP-1, TNF-α, and IL-4 is reduced, thereby allergic reactions are alleviated, and the sensitive symptoms of the skin are relieved to soothe the skin, enhance the skin's resistance to external stimuli, and strengthen the skin's tolerance to stimuli. By inhibiting the expression of TRPV1 protein, the uncomfortable sensations such as heat and pain caused by external stimuli on the skin are reduced.
[0137] Example 5: Synergistic antihistamine effect of soothing and repairing composition
[0138] The experiment of Example 3 was used to compound chamomile extract, sea buckthorn fruit extract and fermentation complex into a soothing and repairing composition. The histamine content was used as an indicator and the CompuSyn software was used to analyze the combined effects of chamomile extract, sea buckthorn fruit extract and fermentation complex in different proportions. The mass concentrations of chamomile extract and sea buckthorn fruit extract were both 8 μg / ml.
[0139] This embodiment provides a soothing and repairing composition 1-5.
[0140] The soothing and repairing composition 1 includes chamomile extract, sea buckthorn fruit extract and fermentation complex, and the mass ratio of the chamomile extract, sea buckthorn fruit extract and fermentation complex is 1:1:0.4 (for example, 1.2μ / ml: the dosage of chamomile extract is 0.5μg / ml, the dosage of sea buckthorn fruit extract is 0.5μg / ml, and the dosage of fermentation complex is 0.2μg / ml).
[0141] The soothing and repairing composition 2 includes chamomile extract, sea buckthorn fruit extract and fermentation complex, and the mass ratio of the chamomile extract, sea buckthorn fruit extract and fermentation complex is 1:1:0.6 (for example, 1.3μ / ml: the dosage of chamomile extract is 0.5μg / ml, the dosage of sea buckthorn fruit extract is 0.5μg / ml, and the dosage of fermentation complex is 0.3μg / ml).
[0142] The soothing and repairing composition 3 includes chamomile extract, sea buckthorn fruit extract and fermentation complex, and the mass ratio of the chamomile extract, sea buckthorn fruit extract and fermentation complex is 1:1:0.8 (for example, 1.4μ / ml: the dosage of chamomile extract is 0.5μg / ml, the dosage of sea buckthorn fruit extract is 0.5μg / ml, and the dosage of fermentation complex is 0.4μg / ml).
[0143] The soothing and repairing composition 4 includes chamomile extract, sea buckthorn fruit extract and fermentation complex, and the mass ratio of the chamomile extract, sea buckthorn fruit extract and fermentation complex is 1:1:0.2 (for example, 1.1μ / ml: the dosage of chamomile extract is 0.5μg / ml, the dosage of sea buckthorn fruit extract is 0.5μg / ml, and the dosage of fermentation complex is 0.1μg / ml).
[0144] The soothing and repairing composition 5 includes chamomile extract, sea buckthorn fruit extract and fermentation complex, and the mass ratio of the chamomile extract, sea buckthorn fruit extract and fermentation complex is 1:1:1 (for example, 1.5μ / ml: the dosage of chamomile extract is 0.5μg / ml, the dosage of sea buckthorn fruit extract is 0.5μg / ml, and the dosage of fermentation complex is 0.5μg / ml).
[0145] The fermentation complex is obtained by fermenting Pediococcus pentosaceus and white tea, and the specific preparation method is as follows:
[0146] The method for preparing the fermentation complex comprises the following steps:
[0147] The bacterial suspension of Pediococcus pentosaceus was inoculated into YM solid culture medium for activation culture, the activation culture temperature was 30° C., the activation culture time was 30 h, and the activated Pediococcus pentosaceus was obtained;
[0148] The activated Pediococcus pentosaceus is inoculated into a YM liquid culture medium for expansion at a temperature of 32° C. for 34 hours to obtain the Pediococcus pentosaceus seed solution.
[0149] The seed liquid of Pediococcus pentosaceus is inoculated into a culture medium containing white tea powder at an inoculation amount of 2% for fermentation at a fermentation temperature of 29° C. for 36 hours to obtain the fermentation complex.
[0150] The culture medium containing white tea powder includes the following components in percentage by mass:
[0151] 0.8% white tea powder, 3% glucose, 1.0% soy peptone, and the balance is water.
[0152] The effects of different soothing and repairing compositions on histamine are shown in Table 4.
[0153] Table 4 Effects of different soothing and repairing compositions on the action of histamine n=6)
[0154] Group CI value Soothing and repairing composition 1 <![CDATA[0.2032 *# ]]> Soothing Repair Composition 2 <![CDATA[0.1723 *# ]]> Soothing Repair Composition 3 <![CDATA[0.2114 *# ]]> Soothing and repairing composition 4 <![CDATA[0.4059 *# ]]> Soothing and repairing composition 5 <![CDATA[0.4378 *# ]]>
[0155] Compared with group A, the soothing and repairing composition * P<0.1, soothing repair composition compared with group B # P<0.1.
[0156] From the data in Table 4, it can be seen that fermenting Pediococcus pentosaceus and white tea to obtain a fermentation complex, and then combining it with chamomile extract and sea buckthorn fruit extract, especially using a specific mass ratio, has a better anti-histamine synergistic effect and can achieve better soothing and repairing effects.
[0157] The soothing and repairing composition used in the present application inhibits the influx of calcium ions and reduces the release of histamine, thereby alleviating allergic reactions and relieving skin sensitivity symptoms to soothe the skin, enhance the skin's resistance to external stimuli, and strengthen the skin's tolerance to stimuli.
[0158] The compositions prepared from the soothing and repairing compositions 1-5 were used as samples to test their safety. The specific method is as follows:
[0159] Number of testers: 20 people, 10 males and 10 females, aged 19-48 years old. The volunteers met the selection criteria for subjects in the human skin patch test in the "Technical Specifications for Safety of Cosmetics" (2015 edition).
[0160] Test method: The composition prepared from the soothing and repairing composition 1-5 was subjected to a patch test. Qualified patch test equipment was selected. The test substance was placed in the patch tester with about 0.020-0.025 ml by the closed patch test method. The test substance was applied to the curved side of the forearm of the subject with external medical tape. The test substance was evenly applied to the skin by lightly pressing with the palm of the hand. After 24 hours, the test substance patch tester was removed. The skin reaction was observed at 0.5, 24, and 48 hours after the removal of the test substance patch tester. The results were recorded according to the skin reaction grading standard in the "Cosmetic Safety Technical Specifications" (2015 Edition). Table 5 shows the grading standard for adverse skin reactions.
[0161] Table 5
[0162]
[0163] The results of the human skin closed patch test showed that there was no positive reaction in 20 people. According to the "Technical Specifications for Safety of Cosmetics" (2015 edition), the test substance will not cause adverse skin reactions in this batch of subjects.
[0164] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present application rather than to limit the scope of protection of the present application. Although the present application has been described in detail with reference to the preferred embodiments, ordinary technicians in this field should understand that the technical solution of the present application can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present application.
Claims
1. A soothing and repairing composition, characterized in that: The soothing and repairing composition comprises chamomile extract and sea buckthorn fruit extract; The mass ratio of the chamomile extract to the seabuckthorn fruit extract is 1:(1-4).
2. The soothing and repairing composition according to claim 1, characterized in that: The mass ratio of the chamomile extract to the seabuckthorn fruit extract is 1:1 or 1:
2.
3. The soothing and repairing composition according to claim 1, characterized in that: The mass concentration of the chamomile extract is 1-16 μg / ml; the mass concentration of the seabuckthorn fruit extract is 1-16 μg / ml.
4. The soothing and repairing composition according to claim 3, characterized in that: The mass concentration of the chamomile extract is 4-16 μg / ml; the mass concentration of the seabuckthorn fruit extract is 4-16 μg / ml.
5. The soothing and repairing composition according to claim 1, characterized in that: The soothing and repairing composition also includes a fermentation complex; The fermentation complex is obtained by fermenting Pediococcus pentosaceus and white tea.
6. The soothing and repairing composition according to claim 1, characterized in that: The mass ratio of the chamomile extract, the seabuckthorn fruit extract and the fermentation complex is 1:1:(0.4-0.8).
7. The soothing and repairing composition according to claim 5, characterized in that: The method for preparing the fermentation complex comprises the following steps: The seed liquid of Pediococcus pentosaceus is inoculated into a culture medium containing white tea powder for fermentation to obtain the fermentation complex.
8. The soothing and repairing composition according to claim 1, characterized in that: The preparation method of the chamomile extract comprises the following steps: Chamomile is ground into powder, 70-90% ethanol is added for ultrasonic extraction, then filtered, and then preparative liquid chromatography is used to separate and purify the enriched substances, and flavonoid compound segment samples are taken and dried to obtain yellow powder to obtain chamomile extract.
9. The soothing and repairing composition according to claim 1, characterized in that: The preparation method of the seabuckthorn fruit extract comprises the following steps: The seabuckthorn fruit is ground into powder, 50-70% ethanol is added for ultrasonic extraction, and then filtered. The enriched material is separated and purified by preparative liquid chromatography, and a proanthocyanidin segment sample is taken and dried to obtain a wine red powder to prepare the seabuckthorn fruit extract.
10. Use of the soothing and repairing composition according to any one of claims 1 to 9 in the preparation of skin care products.
Citation Information
Cited By
Composition with soothing and repairing effects and application thereof
CN119499116A
